Scott M. Rocklage Ph.D. became a managing partner at 5AM Ventures Management during the year of 2004. The firm was founded in 2002 and has offices based in Menlo Park, CA and Boston, MA. 5AM Ventures Management actively invests in next-gen life science companies, focusing mainly on the discovery and development of therapeutics, drug delivery technologies, reagents and research instruments.
The company has invested in over 54 companies to this date. He served as the chairman and CEO of Cubist Pharmaceuticals, the president and CEO of Nycomed and a few positions in R&D for the company Salutar and Catalytica.
For over three decades, Dr. Rocklage has maintained his leadership during his healthcare management experiences and also won the approval from the FDA for three new US drug applications: Omniscan, Teslascan and Cubicin.
During a recent sit down, Dr. Rocklage explained that he developed his idea for his business, 5AM Ventures by wanting a life science based firm.
The name came to be because the firm is in the company formation business and is still in its early stages, hence the name “5AM”. His typical days are random, some days he is immersed in his life science studies and other days he’s working with a portfolio company’s management team or attending board meetings.
Dr. Rocklage shares that he is excited to see superior growth in targeting specific mutations or genotypes that will eventually treat cancers in a rather unique way. As an entrepreneur, Dr. Scott Rocklage shares that the one thing he’d do over and over again and even recommend to others is, “don’t be afraid of measured risk-taking.”
Scott Rocklage, Ph.D. graduated with a B.S. degree in Chemistry from the University of California, he also received his Ph.D. in Chemistry at the Massachusetts Institute of Technology (MIT). During his studies at MIT, Scott would conduct his research in Nobel Prize winner, Richard Schrock’s laboratory. Read more: Scott Racklage | Crunchbase
He is actively a member of Rennovia, Cidara and Kinestral, serving all as their Board Chairman. Dr. Rocklage has invented and co-invented over 30 US patents, he also has over a hundred peer-reviewed publications under his belt.
Learn more about Scott Rocklage: